
    
      Matrix metalloproteinases have been implicated in the cartilage degradation that occurs in
      osteoarthritis. PG-530742 inhibits some of these matrix metalloproteinases, thus potentially
      limiting cartilage degradation and disease progression. This study will test the efficacy and
      safety of PG-530742 in the treatment of mild to moderate knee osteoarthritis.
    
  